Yahoo
OTC Markets OTCQX - Delayed Quote USD

Cardiff Lexington Corporation (CDIX)

0.0130 +0.0025 (+23.81%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for CDIX
  • Previous Close 0.0105
  • Open 0.0150
  • Bid 0.0140 x 4607700
  • Ask 0.0213 x 1000000
  • Day's Range 0.0130 - 0.0170
  • 52 Week Range 0.0096 - 6.0000
  • Volume 413,923
  • Avg. Volume 57,407
  • Market Cap (intraday) 203,285
  • Beta (5Y Monthly) 1.97
  • PE Ratio (TTM) --
  • EPS (TTM) -1.0000
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Cardiff Lexington Corporation, through its subsidiaries, provides orthopedics, spine care, and pain management services in the United States. The company operates through two segments, Healthcare and Real Estate. The company provides diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. It also engages in real estate business. The company also offers orthopedic and pain procedure services, including hip and knee replacement, shoulder reconstruction, fracture care, and hand surgery, as well as spinal surgery. It serves personal injury attorneys, insurance carriers, physical therapy providers, and chiropractic care providers. The company was formerly known as Cardiff International, Inc. and changed its name to Cardiff Lexington Corporation in January 2018. Cardiff Lexington Corporation is based in Lexington, Kentucky.

cardifflexington.com

15

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CDIX
99.77%
S&P 500 (^GSPC)
10.73%

1-Year Return

CDIX
99.57%
S&P 500 (^GSPC)
11.11%

3-Year Return

CDIX
99.98%
S&P 500 (^GSPC)
81.91%

5-Year Return

CDIX
99.97%
S&P 500 (^GSPC)
64.59%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -92.05%

  • Return on Assets (ttm)

    -2.42%

  • Return on Equity (ttm)

    -201.78%

  • Revenue (ttm)

    10.21M

  • Net Income Avi to Common (ttm)

    -10.73M

  • Diluted EPS (ttm)

    -1.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    217.65k

  • Total Debt/Equity (mrq)

    645.78%

  • Levered Free Cash Flow (ttm)

    -11.79M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: